{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T20:00:57Z","timestamp":1781812857449,"version":"3.54.5"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T00:00:00Z","timestamp":1559260800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T00:00:00Z","timestamp":1559260800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s12185-019-02675-1","type":"journal-article","created":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T11:02:35Z","timestamp":1559300555000},"page":"506-511","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Complete response following toxic epidermal necrolysis in relapsed adult T cell leukemia\/lymphoma after haploidentical stem cell transplantation"],"prefix":"10.1007","volume":"110","author":[{"given":"Satoshi","family":"Morishige","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Nishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Saruta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiko","family":"Arakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Yamasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuki","family":"Oya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritsuko","family":"Seki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maki","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutoshi","family":"Aoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihiko","family":"Mouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Osaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Ohshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Nagafuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,31]]},"reference":[{"key":"2675_CR1","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1007\/s12185-018-2430-6","volume":"107","author":"H Miyoshi","year":"2018","unstructured":"Miyoshi H, Ohshima K. Epidemiology of malignant lymphoma and recent progress in research on adult T-cell leukemia\/lymphoma in Japan. Int J Hematol. 2018;107:420\u20137.","journal-title":"Int J Hematol"},{"key":"2675_CR2","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1182\/blood-2015-03-632489","volume":"126","author":"H Katsuya","year":"2015","unstructured":"Katsuya H, Ishitsuka K, Utsunomiya A, Hanada S, Eto T, Moriuchi Y, et al. Treatment and survival among 1594 patients with ATL. Blood. 2015;126:2570\u20137.","journal-title":"Blood"},{"key":"2675_CR3","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1182\/blood-2011-07-368233","volume":"119","author":"J Kanda","year":"2012","unstructured":"Kanda J, Hishizawa M, Utsunomiya A, Taniguchi S, Eto T, Moriuchi Y, et al. Impact of graft-versus-host disease on outcomes after allogeneic hematopoietic cell transplantation for adult T-cell leukemia: a retrospective cohort study. Blood. 2012;119:2141\u20138.","journal-title":"Blood"},{"key":"2675_CR4","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1200\/JCO.2011.37.3472","volume":"30","author":"T Ishida","year":"2012","unstructured":"Ishida T, Joh T, Uike N, Yamamoto K, Utsunomiya A, Yoshida S, et al. Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study. J Clin Oncol. 2012;30:837\u201342.","journal-title":"J Clin Oncol"},{"key":"2675_CR5","doi-asserted-by":"publisher","first-page":"3426","DOI":"10.1200\/JCO.2016.67.8250","volume":"34","author":"S Fuji","year":"2016","unstructured":"Fuji S, Inoue Y, Utsunomiya A, Moriuchi Y, Uchimaru K, Choi I, et al. Pretransplantation anti-CCR5 antibody mogamulizumab against adult T-cell leukemia\/lymphoma is associated with significantly increased risks of severe and corticosteroid-refractory graft-versus-host disease, nonrelapse mortality, and overall mortality. J Clin Oncol. 2016;34:3426\u201333.","journal-title":"J Clin Oncol"},{"key":"2675_CR6","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1016\/j.bbmt.2016.05.017","volume":"22","author":"T Sugio","year":"2016","unstructured":"Sugio T, Kato K, Aoki T, Ohta T, Saito N, Yoshida S, et al. Mogamulizumab treatment prior to allogeneic hematopoietic stem cell transplantation induces severe acute graft-versus-host disease. Biol Blood Marrow Transplant. 2016;22:1608\u201314.","journal-title":"Biol Blood Marrow Transplant"},{"key":"2675_CR7","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1038\/bmt.2012.268","volume":"48","author":"Y Ito","year":"2013","unstructured":"Ito Y, Miyamoto T, Chong Y, Aoki T, Kato K, Akashi K, et al. Successful treatment with anti-CC chemokine receptor 4 MoAb of relapsed adult T-cell leukemia\/lymphoma after umbilical cord blood transplantation. Bone Marrow Transplant. 2013;48:998\u20139.","journal-title":"Bone Marrow Transplant"},{"key":"2675_CR8","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1080\/10428194.2018.1427859","volume":"59","author":"T Ando","year":"2018","unstructured":"Ando T, Kojima K, Sano H, Kidoguchi K, Kusaba K, Yoshimura M, et al. Successful treatment of post-transplant relapsed adult T cell leukemia after cord blood transplantation with low-dose, short-term lenalidomide. Leuk Lymphoma. 2018;59:2474\u20137.","journal-title":"Leuk Lymphoma"},{"key":"2675_CR9","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/j.1365-2141.1991.tb08051.x","volume":"79","author":"M Shimoyama","year":"1991","unstructured":"Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87). Br J Haematol. 1991;79:428\u201337.","journal-title":"Br J Haematol"},{"key":"2675_CR10","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/pin.12515","volume":"67","author":"A Ichikawa","year":"2017","unstructured":"Ichikawa A, Miyoshi H, Yamauchi T, Arakawa F, Kawano R, Muta H, et al. Composite lymphoma of peripheral T-cell lymphoma and Hodgkin lymphoma, mixed cellularity type; pathological and molecular analysis. Pathol Int. 2017;67:194\u2013201.","journal-title":"Pathol Int"},{"key":"2675_CR11","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/sj.leu.2403682","volume":"19","author":"T Fukushima","year":"2005","unstructured":"Fukushima T, Miyazaki Y, Honda S, Kawano F, Moriuchi Y, Masuda M, et al. Allogeneic hematopoietic stem cell transplantation provides sustained long-term survival for patients with adult T-cell leukemia\/lymphoma. Leukemia. 2005;19:829\u201334.","journal-title":"Leukemia"},{"key":"2675_CR12","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1182\/blood-2012-03-414490","volume":"120","author":"T Ishida","year":"2012","unstructured":"Ishida T, Hishizawa M, Kato K, Tanosaki R, Fukuda T, Taniguchi S, et al. Allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia-lymphoma with special emphasis on preconditioning regimen: a nationwide retrospective study. Blood. 2012;120:1734\u201341.","journal-title":"Blood"},{"key":"2675_CR13","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/hon.2558","volume":"37","author":"K Kato","year":"2019","unstructured":"Kato K, Uike N, Wake A, Yoshimitsu M, Tobai T, Sawayama Y, et al. The outcome and characteristics of patients with relapsed adult T cell leukemia\/lymphoma after allogeneic hematopoietic stem cell transplantation. Hematol Oncol. 2019;37:54\u201361.","journal-title":"Hematol Oncol."},{"key":"2675_CR14","doi-asserted-by":"publisher","first-page":"5473","DOI":"10.1182\/blood-2010-12-327791","volume":"117","author":"A Umino","year":"2011","unstructured":"Umino A, Nakagawa M, Utsunomiya A, Tsukasaki K, Taira N, Katayama N, et al. Clonal evolution of adult T-cell leukemia\/lymphoma takes place in the lymph nodes. Blood. 2011;117:5473\u20138.","journal-title":"Blood"},{"key":"2675_CR15","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1007\/s12185-016-2049-4","volume":"104","author":"S Aoki","year":"2016","unstructured":"Aoki S, Firouzi S, Lopez Y, Yamochi T, Nakano K, Uchimaru K, et al. Transition of adult T-cell leukemia\/lymphoma clones during clinical progression. Int J Hematol. 2016;104:330\u20137.","journal-title":"Int J Hematol"},{"key":"2675_CR16","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1002\/hon.2242","volume":"35","author":"S Shiratori","year":"2017","unstructured":"Shiratori S, Ohhigashi H, Ito S, Kudo K, Adachi M, Minamimoto T, et al. Late onset toxic epidermal necrolysis induced by mogamulizumab, an anti-CC chemokine receptor 4 antibody for the treatment of adult T-cell leukaemia\/lymphoma. Hematol Oncol. 2017;35:138\u201340.","journal-title":"Hematol Oncol"},{"key":"2675_CR17","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1111\/cas.12116","volume":"104","author":"T Ishida","year":"2013","unstructured":"Ishida T, Ito A, Sato F, Kusumoto S, Iida S, Inagaki H, et al. Stevens-Johnson Syndrome associated with mogamulizumab treatment of adult T-cell leukemia\/lymphoma. Cancer Sci. 2013;104:647\u201350.","journal-title":"Cancer Sci"},{"key":"2675_CR18","doi-asserted-by":"publisher","first-page":"606","DOI":"10.2340\/00015555-2027","volume":"95","author":"T Honda","year":"2015","unstructured":"Honda T, Hishizawa M, Kataoka TR, Ohmori K, Takaori-Kondo A, Miyachi Y, et al. Stevens-Johnson syndrome associated with mogamulizumab-induced deficiency of regulatory T cells in an adult T-cell leukaemia patient. Acta Derm Venereol. 2015;95:606\u20137.","journal-title":"Acta Derm Venereol"},{"key":"2675_CR19","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1111\/j.1346-8138.1997.tb02308.x","volume":"24","author":"H Takeda","year":"1997","unstructured":"Takeda H, Mitsuhashi Y, Kondo S, Kato Y, Tajima K. Toxic epidermal necrolysis possibly linked to hyperacute graft-versus-host disease after allogeneic bone marrow transplantation. J Dermatol. 1997;24:635\u201341.","journal-title":"J Dermatol"},{"key":"2675_CR20","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1111\/cup.12986","volume":"44","author":"H Naik","year":"2017","unstructured":"Naik H, Lockwood S, Saavedra A. A pilot study comparing histological and immunophenotypic patterns in stage 4 skin graft vs host disease from toxic epidermal necrolysis. J Cutan Pathol. 2017;44:857\u201360.","journal-title":"J Cutan Pathol"},{"key":"2675_CR21","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1200\/JCO.2008.20.3737","volume":"27","author":"CP Castaneda","year":"2009","unstructured":"Castaneda CP, Brandenburg NA, Bwire R, Burton GH, Zeldis JB. Erythema multiforme\/Stevens-Johnson syndrome\/toxic epidermal necrolysis in lenalidomide-treated patients. J Clin Oncol. 2009;27:156\u20137.","journal-title":"J Clin Oncol"},{"key":"2675_CR22","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1182\/blood-2011-04-348292","volume":"118","author":"E Kneppers","year":"2011","unstructured":"Kneppers E, van der Holt B, Kersten MJ, Zweegman S, Meijer E, Huls G, et al. Lenalidomide maintenance after nonmyeloablative allogeneic stem cell transplantation in multiple myeloma is not feasible: results of the HOVON 76 Trial. Blood. 2011;118:2413\u20139.","journal-title":"Blood"},{"key":"2675_CR23","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/j.bbmt.2014.04.014","volume":"20","author":"M Alsina","year":"2014","unstructured":"Alsina M, Becker PS, Zhong X, Adams A, Hari P, Rowley S, et al. Lenalidomide maintenance for high-risk multiple myeloma after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2014;20:1183\u20139.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"134\u201342","key":"2675_CR24","first-page":"e3","volume":"41","author":"C Wolschke","year":"2013","unstructured":"Wolschke C, Stubig T, Hegenbart U, Schonland S, Heinzelmann M, Hildebrandt Y, et al. Postallograft lenalidomide induces strong NK cell-mediated antimyeloma activity and risk for T cell-mediated GvHD: Results from a phase I\/II dose-finding study. Exp Hematol. 2013;41(134\u201342):e3.","journal-title":"Exp Hematol"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-019-02675-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-019-02675-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-019-02675-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T23:32:59Z","timestamp":1590795179000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-019-02675-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,31]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["2675"],"URL":"https:\/\/doi.org\/10.1007\/s12185-019-02675-1","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,31]]},"assertion":[{"value":"2 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}